Immunic GAAP EPS of -$0.80 beats by $0.37 (IMUX:NASDAQ)
· seekingalpha.com
Immunic (IMUX) Q2 GAAP EPS beats; cash runway into late 2027.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...